David R Harper

Nota: Este archivo abarca los artículos publicados por el autor desde el 1 de Marzo de 2008. Para fechas anteriores realice una búsqueda entrecomillando su nombre.

A nurse prepares a vaccine against Ebola in Goma in August 2019. Photo: Getty Images.

The world’s second-largest Ebola outbreak is ongoing in the Democratic Republic of the Congo (DRC) and experts from around the world have been parachuted in to support the country’s operation to stamp out the outbreak. The signs are encouraging, but we need to remain cautious.

In such emergencies, little thought is usually given to what happens to the body-fluid samples taken during the course of the outbreak after the crisis is over. What gets left behind has considerable implications for global biosecurity.

Having unsecured samples poses the obvious risk of accidental exposures to people who might come into contact with them, but what of the risk of malicious use?…  Seguir leyendo »

The Ebola crisis of 2014–16 mobilized unprecedented financial assistance for West Africa to strengthen outbreak surveillance to prevent another crisis. The region has developed an ambitious blueprint over the last two years, but the effort has now reached a tipping point for success. Careful and transparent transition planning, and sensitivity to the unique diversity of the region, will be key to realizing the potential and offering an excellent model for Africa in the future.

The West African region is recognized by the global public health community as being particularly vulnerable to infectious disease outbreaks, including those caused by diseases that jump the species barrier from animals.…  Seguir leyendo »